The development of the pharmaceutical e-commerce market continues to improve, and online pharmaceutical sales of pharmaceutical companies have increased significantly

In recent years, under the influence of a series of medical reform policies such as medical insurance negotiations, mass procurement, and two-invoice system, the marketing model of pharmaceutical companies has gradually begun to transform from a traditional marketing model based on human resources to digitalization
.
Especially under the catalysis of the epidemic, it has accelerated the pace of pharmaceutical companies to enter the line
.
At present, as far as the author knows, the development of digital marketing of pharmaceutical companies has begun to accelerate, and more and more new breakthroughs are being made
.
Recently, Pien Tze Huang announced the report for the third quarter of 2021, with total revenue of 6.
012 billion yuan, a year-on-year increase of 20.
55%; net profit of 2.
011 billion yuan, a year-on-year increase of 51.
36%
.
Among them, it is worth mentioning that the announcement showed that the reason for the company's substantial increase in net profit was the addition of online Pien Tze Huang Pharmacy Tmall flagship store and JD flagship store and other marketing channels
.
The industry believes that the substantial increase in Pien Tze Huang's net profit is a successful case of deepening cooperation between pharmaceutical companies, platforms, and end users to build a mature online sales network
.
Through online marketing channels, pharmaceutical companies can not only reduce sales costs, but also enrich the supply of medicines, so that more good medicines can enter thousands of households and benefit more patients
.
In fact, as the medical reform continues to deepen, both innovative pharmaceutical companies and traditional pharmaceutical companies are paying more and more attention to the expansion of the out-of-hospital market and online channels
.
It is understood that this is mainly due to the fact that China's digital system and ecology are at the forefront of the world in many aspects: whether it is the underlying architecture, technological empowerment, or user habits, it has a better foundation than other regions
.
Therefore, besides Pien Tze Huang, there are not a few pharmaceutical companies that have deployed online sales in recent years
.
On March 16 this year, BeiGene, an innovative biotechnology company, reached a strategic cooperation with the domestic Internet + medical and health company 1Yaowang
.
In addition, since 2020, pharmaceutical companies such as Besunyen, Biostime, Yang Sen, China Resources Sanjiu, Jiangzhong, Zhongsheng Pharmaceutical, Tasly, and Silian have also reached cooperation with the pharmacist
.
The industry believes that, driven by my country’s increasing policy support for the development of pharmaceutical e-commerce, my country’s pharmaceutical e-commerce industry has entered a "golden period" of development. .
In the future, with the continuous vigorous empowerment of the Internet, the decentralized medical ecology, combined with the renewed efforts of digital marketing, the scale of pharmaceutical e-commerce will fission faster, and more pharmaceutical companies will deploy Tmall, JD.
com, The online strategic layout of mainstream e-commerce platforms such as Pharmacist Gang will become an inevitable choice for pharmaceutical companies in their future development
.
In general, with the upgrading of the pharmaceutical industry, it is inevitable that the marketing situation of pharmaceutical companies will change
.
According to statistics, in 2020, drug retail offline sales will be 431.
6 billion yuan, an increase of 24.
4 billion yuan from 2019, a growth rate of 6%; online drug sales will increase by 59.
1 billion yuan from 2019, a growth rate of 59 %, the online increment is about twice as much as offline
.
However, it should be noted that for pharmaceutical companies, despite the continuous promotion of policies, the layout of online channels will usher in more development opportunities, but at the same time, competition among companies will further intensify, and industry integration is expected to continue to improve
.
Therefore, in the future, how to continue to further improve online sales capabilities will also be an urgent problem for pharmaceutical companies to solve
.